CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-01 | Goff Brian Chief Executive Officer | Option exercise 10b5-1 | +8,500 | 87,292 | ||
| 2025-03-01 | Goff Brian Chief Executive Officer | Option exercise 10b5-1 | +18,000 | 101,139 | ||
| 2025-03-01 | Goff Brian Chief Executive Officer | Grant or award · Restricted stock units 10b5-1 | +39,000 | 39,000 | ||
| 2025-03-01 | Goff Brian Chief Executive Officer | Grant or award · Stock options (right to buy) 10b5-1 | +142,500 | 142,500 | ||
| 2025-03-01 | Goff Brian Chief Executive Officer | Option exercise · Restricted stock units 10b5-1 | −8,500 | 8,500 | ||
| 2025-03-01 | Goff Brian Chief Executive Officer | Option exercise · Restricted stock units 10b5-1 | −18,000 | 36,000 | ||
| 2025-03-01 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +3,833 | 48,235 | ||
| 2025-03-01 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +4,000 | 51,098 | ||
| 2025-03-01 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +5,667 | 55,578 | ||
| 2025-03-01 | Gheuens Sarah Chief Medical Officer | Grant or award · Restricted stock units 10b5-1 | +12,000 | 12,000 | ||
| 2025-03-01 | Gheuens Sarah Chief Medical Officer | Grant or award · Stock options (right to buy) 10b5-1 | +43,500 | 43,500 | ||
| 2025-03-01 | Gheuens Sarah Chief Medical Officer | Option exercise · Restricted stock units 10b5-1 | −3,833 | 0 | ||
| 2025-03-01 | Gheuens Sarah Chief Medical Officer | Option exercise · Restricted stock units 10b5-1 | −4,000 | 4,000 | ||
| 2025-03-01 | Gheuens Sarah Chief Medical Officer | Option exercise · Restricted stock units 10b5-1 | −5,667 | 11,333 | ||
| 2025-03-01 | Washburn Theodore James Jr. Principal Accounting Officer | Option exercise 10b5-1 | +777 | 6,269 | ||
| 2025-03-01 | Washburn Theodore James Jr. Principal Accounting Officer | Option exercise 10b5-1 | +2,350 | 8,388 | ||
| 2025-03-01 | Washburn Theodore James Jr. Principal Accounting Officer | Option exercise 10b5-1 | +2,450 | 10,141 | ||
| 2025-03-01 | Washburn Theodore James Jr. Principal Accounting Officer | Grant or award · Restricted stock units 10b5-1 | +8,085 | 8,085 | ||
| 2025-03-01 | Washburn Theodore James Jr. Principal Accounting Officer | Grant or award · Restricted stock units 10b5-1 | +6,142 | 6,142 | ||
| 2025-03-01 | Washburn Theodore James Jr. Principal Accounting Officer | Option exercise · Restricted stock units 10b5-1 | −777 | 0 |
Page 17 of 48 · 941 trades